Cytrellis Strengthens Leadership Team in Support of Accelerated Commercial Growth of ellacor® PlatformWOBURN, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Cytrellis Biosystems Inc., a medical technology company specializing in novel aesthetic solutions, today announced the appointment of Karyn Siemasko, Ph.D., as Vice President of Clinical and Medical Affairs; Sarah Brice, RN, BSN, as Vice President of Commercial Strategy; and Oliver Bennett as Chief Business Officer and General Counsel.
Cytrellis’ Next-Generation ellacor® Optimizes Micro-Coring for Enhanced Patient and Provider Experienceellacor to be showcased at the American Society of Aesthetic Plastic Surgery (ASAP) and the American Society for Laser Medicine and Surgery (ASLMS) Meetings
